Fda foia vaccine. As new strains of flu viruses emerge, the U.

Fda foia vaccine Topics Background on classic myocarditis and myocarditis associated with mRNA COVID-19 vaccination (included for reference) On Oct. Templates for EUA submissions for monkeypox (mpox) tests are available to help facilitate the preparation, submission, and authorization of an EUA VAERS is an early-warning monitoring system for vaccine safety. gov/scripts/foi/FOIRequest/index. Spikevax is approved for the prevention of COVID-19 in individuals 18 years of age and older. ICAN sought copies The Vaccine Adverse Event Reporting System (VAERS) is a national vaccine safety surveillance program co-monitored by the Food and Drug Administration (FDA) and the Centers for Disease Control and The . In September, Public Health and Medical Professionals for Transparency sued FDA, claiming the agency denied a request to expedite the release of Pfizer-BioNTech's Covid-19 vaccine review documents via the FDA wants 55 years to process FOIA request over vaccine data | Reuters. FluMist is approved for use in individuals 2 through 49 years of age for the prevention of influenza disease caused by influenza A Pursuant to the Freedom of Information Act (FOIA), 5 USC 552, and Food and Drug Administration (FDA) implementing regulations at 21 CFR Part 20, I am writing to request the drug approval package The FDA is requesting a court to give them 55 years worth of time to provide more than 300,000 pages worth of information on the Pfizer-BioNTech vaccine after a FOIA However, you can get a summary FAERS report for a product by sending a Freedom of Information Act (FOIA) request to FDA. Vaccines, Blood, and Biologics; FDA FOIA Log - June 2024. Part 20, I hereby FDA announced today the approval of Ervebo, the first FDA-approved vaccine for the prevention of Ebola virus disease (EVD), caused by Zaire ebolavirus in individuals 18 years of age and older. S. C. Revelations of poor practices at a contract research company helping to carry out Pfizer’s pivotal covid-19 vaccine trial raise questions about data integrity and regulatory oversight. Key limitations Pursuant to the Freedom of Information Act (FOIA), 5 U. It allows patients, pharmaceutical companies, medical personnel and other users to report concerns about medical events that The U. Vaccine Manufacturers. STN: 125752 Proper Name: COVID-19 Vaccine, mRNA Tradename: SPIKEVAX Manufacturer: Moderna Tx, Inc Indication: For active immunization to prevent coronavirus disease 2019 Introduction. You can also request individual case reports by submitting a FOIA request Meningococcal (Groups A, C, Y, W) Conjugate Vaccine is indicated Active immunization for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y STN: 125769; 125768 Proper Name: Respiratory Syncytial Virus Vaccine Tradename: ABRYSVO Manufacturer: Pfizer Inc. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines to simplify the vaccination schedule STN: BLA 101094 Proper Name: Pneumococcal Vaccine, Polyvalent Tradename: PNEUMOVAX 23 Manufacturer: Merck Sharp & Dohme Corp. Before FDA determines that a vaccine is safe and effective and approves it for use in the United States, the FDA makes adverse event reports related to animal drugs and devices used in animals available on openFDA. On August 22, 2024, the Food and Drug Administration amended the emergency use authorization (EUA) of Pfizer-BioNTech COVID-19 Vaccine to include the 2024-2025 formula. Vaccines and Related Biological Products Advisory Committee. A single dose of a killed rabies virus (RV) vaccine was administered on Day 60. On August 9, 2022, the Secretary of the Department of Health and Human Services (HHS) determined, pursuant to section 564 of the Federal Food, Drug, and Cosmetic (FD&C) Act, that there is a public The FDA approved a second COVID-19 vaccine, Spikevax. Food and Drug Administration FDA approved the first COVID-19 vaccine, which has been known as the Pfizer-BioNTech COVID-19 Vaccine, and is now marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease Vaccines, as with all products regulated by FDA, undergo a rigorous review of laboratory and clinical data to ensure the safety, efficacy, purity and potency of these products. § 552, as amended, and the regulations promulgated by the U. By WESLEY J. Comirnaty vaccine (Pfizer-BioNTech COMIRNATY® COVID 19 Vaccine, mRNA suspension for injection, for intramuscular use), 2. Indication: Indicated for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD First FDA-approved vaccine for the prevention of Ebola virus disease, marking a critical milestone in public health preparedness and response Content current as of: 08/09/2023 Please direct your response to Dr. inadequate immune response to any vaccine, Zenrelia™ should be discontinued at least 28 days to 3 months before any vaccination and should not be administered for at least 28 days afterward. Active immunization of pregnant The FDA, an agency within the U. Based on current information, Pfizer and BioNTech anticipate a 2-dose per patient regimen. , Bldg. The information collected into the VAERS database comes from a wide array of sources, including patients and parents, state health agencies, pharmacies, health care providers, and the makers of Background information on JYNNEOS vaccine, which is licensed to prevent smallpox and monkeypox in individuals 18 and older at high risk of infection and includes information about the EUA for the The FDA approved Ixchiq, the first vaccine for prevention of disease caused by chikungunya virus in individuals 18 years of age and older who are at increased risk of exposure to chikungunya virus. For active immunization of individuals 2 through 49 years of age for the prevention of influenza disease caused by influenza A subtype viruses and type B viruses contained in the vaccine. The FDA is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the On Oct. gov and mRNA-1273. g. Arexvy is approved for the prevention of lower respiratory tract disease caused by RSV. gov, a platform electronically accessible to the general public and available for automated “Although it is conceivable that the FDA might have anticipated that it would face vaccine-related FOIA requests following its approval of COVID vaccines to combat the global pandemic then-raging, it could not have anticipated that a court would order it to produce records in response to COVID-vaccine-related FOIA requests at a rate that FDA-licensed vaccine, COMIRNATY (COVID-19 Vaccine, mRNA). " " Notably, the FDA has identified . Please indicate the maximum dollar amount you are willing to pay for the processing of your request. FOIA Open/Closed Logs. An EUA requires an FDA review of data on Procedural Requirements, Proper FOIA Requests: "The FDA argues that summary judgment is justified because [plaintiff's] request—namely, for only those trials 'that had a safety review period longer than seven days following administration of this vaccine'—did not 'reasonably describe' the records sought. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14 Agenda The meeting presentations will be heard, viewed, captioned, and recorded through an online teleconferencing platform. SMITH. "Reviews FDA recognizes the gravity of the current public health emergency and the importance of facilitating availability, as soon as possible, of vaccines to prevent COVID-19 - vaccines that the public the vaccine causing the event or the clinical seriousness of the event. § 552, for a copy of any Food and Drug Administration (FDA) Form 2877 (“Declaration for Imported Electronic Products FDA is informing healthcare providers and vaccine recipients that PreHevbrio (Hepatitis B Vaccine, Recombinant) has been voluntarily withdrawn from the market by the company, VBI Vaccines Inc Fluzone is a vaccine indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B virus contained in the vaccine. That This is a request under the Freedom of Information Act (FOIA), 5 U. The Vaccine Adverse Event Reporting System (VAERS) is a valuable tool for post-marketing safety surveillance (monitoring after a product has been approved and is on the market). Barring the emergence of a markedly more virulent variant, the FDA anticipates that the composition of COVID-19 vaccines may need to be updated annually, as is done for the seasonal influenza vaccine. gov or . The office that reviews FOIA requests has just 10 employees, according to a declaration filed with the court by Suzann Burk, who heads the FDA’s Division of Disclosure and Oversight Management. PD and LW are members of Public Health and Medical Professionals for Transparency (PHMPT), discussed in this letter. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines STN: 125254 Proper Name: Influenza A (H1N1) 2009 Monovalent Vaccine Tradename: None Manufacturer: CSL Limited Indication: Active immunization of persons ages 6 months and older against influenza U. 1 Previously, a Kaiser Family Foundation survey 2 found that many unvaccinated individuals were concerned the vaccine was unsafe, and some remained unvaccinated because they did not trust the Español. The vaccine is administered intramuscularly (IM) as a series of two 30 μg doses(0. Prominent California attorney Lisa Bloom and her law firm will pay more than $274,000 to The FDA responded to a Freedom of Information Act (FOIA) request for more than 300,000 pages of data related to the licensure of Pfizer's COVID-19 vaccine by proposing a processing schedule Requesters can now submit a FOIA request online: http://www. They “may not have any causal relationship” to each The information collected into the VAERS database comes from a wide array of sources, including patients and parents, state health agencies, pharmacies, health care providers, and the makers of CDC COVID-19 Vaccine Coordination Unit. gov. Food and Drug Administration announced today the approval of Jynneos Smallpox and Monkeypox Vaccine, Live, Non-Replicating, for the prevention of smallpox and monkeypox disease in adults ABRYSVO is indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older, and ocod@fda. Food and Drug 12/1/21, 4:28 PM Wait what? FDA wants 55 years to process FOIA request over vaccine data | Reuters https://www. reuters. Centers for Disease Control and Prevention, facing a Freedom of Information Act lawsuit seeking a vast trove of data about the safety and side-effects of the COVID-19 vaccines, made a WASHINGTON – On Tuesday, U. , LLC Indication: For the prevention of tuberculosis in persons not previously infected with M This acknowledgement comes after eight months of stonewalling from HHS following a Freedom of Information Act (FOIA) request from the nonprofit ICAN, and its founder Del Bigtree. hhs. accessdata. gov; The U. Each ingredient in a vaccine is included for a reason. 71, Rm. Food and Drug On Oct. Currently, a high rate of the known cases in individuals who are uncertain about which COVID-19 vaccine was administered, refrain from donating for a short waiting period (e. Indication: For active immunization of adults 18 years of age and older against influenza disease CBER has unique opportunities for individuals with backgrounds in science or administration to fill positions involved in the regulation and research of blood, vaccines and therapeutics. This Statement of Work is designed toward establishing production capacity and distribution Based on a document Pfizer submitted to the Food and Drug Administration that was made public through a Freedom of Information Act request, the post contended that it found 22 instances of An April 2021 Pfizer COVID-19 vaccine document released by the Food and Drug Administration continues to be taken out of response to a Freedom of Information Act (FOIA) request about adverse report directly to the Vaccine Adverse Event Reporting System (VAERS). gov means it’s official. This is the main page for the CBER Vaccines and Related Biological Products Advisory Committee (VRBPAC) December 12, 2024 meeting announcement and materials. Food and Drug Administration to publicly disclose more information underpinning its authorization of COVID-19 vaccines, after failing to 12/1/21, 4:28 PM Wait what? FDA wants 55 years to process FOIA request over vaccine data | Reuters https://www. Food and Drug ABRYSVO is a vaccine approved by the FDA for pregnant individuals at 32 through 36 weeks gestational age to prevent LRTD and severe LRTD caused by RSV in infants from birth through 6 months of age. STN: 125254 Proper Name: Influenza A (H1N1) 2009 Monovalent Vaccine Tradename: None Manufacturer: CSL Limited Indication: Active immunization of persons ages 6 months and older against influenza On Oct. 214 Moderna COVID-19 Investigational Bivalent Vaccine (Original + Omicron) Moderna, Inc. Vaccine Efficacy – First COVID-19 Occurrence From 14 Days After Dose 2 – Subjects Without Evidence of Infection Prior to 14 Days STN: BL 101069 Proper Name: Measles, Mumps and Rubella Virus Vaccine Live Tradename: M-M-R II Manufacturer: Merck Sharp & Dohme LLC Indication: M-M-R II is a vaccine indicated for active The FDA approved a second COVID-19 vaccine, Spikevax. Paul D Thacker reports In autumn 2020 Pfizer’s chairman and chief executive, Albert Bourla, released an open letter to the billions of people around the world who were investing their FDA must ensure that recipients of the vaccine under an EUA are informed, to the extent practicable given the applicable circumstances, that FDA has authorized the emergency use of the vaccine, of Today, the U. Centers for Disease Control and Prevention (CDC) had released a wholly redacted, 148-page study on myocarditis occurring Competing interests: PD and LW helped organize the Coalition Advocating for Adequately Licensed Medicines (CAALM), which formally petitioned the FDA to refrain from fully approving any covid-19 vaccine last year (docket FDA-2021-P-0786). This virus can spread to anyone through close, personal, often skin-to-skin contact. Federal government websites often end in . Before sharing sensitive information, make sure you're on a federal government site. government false information in connection with a COVID-19 pandemic A federal judge has ordered the U. U. Key strengths Rapidly detects potential safety problems Can detect rare adverse events. com/legal/government/wait-what-fda-wants-55 The AstraZeneca vaccine is not authorized for use in the U. Max Amount: $ On Oct. Indication: For active immunization for mpox is a rare disease that is caused by infection with mpox virus. STN: 125706 Proper Name: remestemcel-L-rknd Tradename: RYONCIL Manufacturer: Mesoblast, Inc. The FDA approves FluMist for self- or caregiver-administration. to Answer FOIA on Vaccine-Approval Data. Max Amount: $ “It is important for the FDA to perform a careful line-by-line, word-by-word review of all responsive records before producing them in response to a FOIA request,” said Suzann Burk, who heads U. FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) held a virtual meeting on June 28, 2022, to publicly discuss whether a change to the current vaccine Guidance for Industry: FDA Review of Vaccine Labeling Requirements for Warnings, Use Instructions, and Precautionary Information 10/2004. For example, as part of our commitment to COVID-19 vaccine transparency, we convened FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) for an open committee meeting to STN: 125297 Proper Name: Influenza Virus Vaccine Tradename: Agriflu Manufacturer: Seqirus Inc. 71, Silver Spring, MD 20993-0002, 202-657-8533 The Blood Products Advisory Committee (BPAC) reviews and evaluates available data concerning the safety, effectiveness, and appropriate use of blood, products derived from blood and serum or The drug labels and other drug-specific information on this Web site represent the most recent drug listing information companies have submitted to the Food and Drug Administration (FDA). For detailed information on our fee schedule, please see FDA’s FOIA page. 6306 As new strains of flu viruses emerge, the U. A canine multivalent modified live virus (MLV) vaccine was administered on Days 28 and 60. F. They are also members of Public Health and Medical Professionals for Transparency, discussed in this letter. com/legal/government/wait-what-fda-wants-55 The FDA, an agency within the U. November 22, 2021 7:34 AM FDA approved Arexvy, the first RSV vaccine approved for use in the U. gov content to reflect these changes. fda. 3 mL each)3 weeks apart. In addition, PD has received travel funds from the European Respiratory Society STN: 103050 Proper Name: BCG Live Tradename: BCG Vaccine Manufacturer: Organon Teknika Corp. Food and Drug Pfizer-BioNTech COVID-19 Vaccine VRBPAC Briefing Document Table 14. Today, the U. Today, the FDA issued the first emergency use authorization (EUA) for a vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 Nine pages of adverse event reports from Pfizer-BioNTech in relation to its COVID-19 vaccine are not confirmed adverse events to the shot. A federal judge has ordered the U. The VAERS toll-free number is 1-800-822-7967 or you may report online to www. In addition, Both companies aspire to have an FDA-approved or authorized vaccine ready for administration in the US by October 31, 2020. Sussan Paydar or Kathleen Hayes, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave. Information about the Vaccine Adverse Event Reporting System (VAERS), which is a national vaccine safety surveillance program co-sponsored by the Food and Drug Administration (FDA) and the Centers The agency “has been dealing with an unprecedented workload requiring FOIA productions involving approximately 5. 2014 (PDF-729KB) In the event of a public health emergency, the FDA may issue an Emergency Use Authorization (EUA) to facilitate the availability and the use of a vaccine. The FDA agreed to. Food and Drug Administration Search Menu; Search FDA Submit search. *Please note that requests Prominent California attorney Lisa Bloom and her law firm will pay more than $274,000 to resolve claims that they gave the U. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. cfm. FDA Will Take 55 Years. R. Food and Drug Administration to publicly disclose more information underpinning its authorization of COVID-19 vaccines, after failing to persuade the court to Case in point: Some activists sent the FDA a Freedom of Information Act. June 28, 2022. Vaccines, Blood, and Biologics; Animal and Veterinary; Original FOI Summary - 04. Food and Drug FDA's Center for Veterinary Medicine is responsible for assuring that animal drugs and medicated feeds are safe and effective and that food from treated animals is safe to eat. vaers. Page 4 – Pfizer Inc. Food and Drug Administration approved Abrysvo (Respiratory Syncytial Virus Vaccine), the first vaccine approved for use in pregnant individuals to prevent lower Competing interests: PD and LW helped organize two Citizen Petitions to the FDA related to covid-19 vaccines (dockets FDA-2021-P-0786 and FDA-2023-P-0360). Neal Bataller at the Food and Drug Administration, Center for Veterinary Medicine, Division of Surveillance, HFV-210, 7519 Standish Place, Rockville, Maryland 20855. FOIA; HHS. If you are seeking copies of records released under previous FOIA requests, please use the Closed FOIA Log, as that list reflects which requests have already been processed. mil. The Vaccine Adverse Event Reporting System (VAERS) is a national vaccine safety surveillance program co-sponsored by the Food and Drug Administration (FDA) and the Centers for Disease Control and As per the FDA Freedom of Information Act (FOIA) regarding the 1. Inaccurate information about these vaccines, particularly the mRNA COVID-19 vaccines, continues to circulate and could result in vaccine hesitancy, which in turn could lead to lower uptake of FDA spokeswoman Alison Hunt also said health care providers must report any death following vaccination, even if it is unclear whether the vaccine was the cause. That The FDA expanded the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory U. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines Product approval information for Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant also known as Gardasil. FDA Review of Efficacy and Safety of BNT162b2 vaccine group (N=60): healthy Dose levels: 1, 3, 10, 20, and 30 µg adults aged 18 to 55 years (12 per dosage cohort) A federal judge has ordered the U. Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein) Active immunization for the prevention of invasive disease caused by S. Subsequently, FDA reissued the letter of authorization on September 22, 2021, 11 October 20, FOR FURTHER INFORMATION CONTACT: Prabhakara Atreya or Kathleen Hayes, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave. 2022-361 Freedom of Information Act (FOIA) request for records regarding: Package Insert and In March 2024, anti-vaccine advocates claimed that the U. ) June 30, 2022. 30. We are in the process of updating FDA. 2 strain The FDA's glacial time frame for releasing documents on the Pfizer/BioNTech vaccine is only the latest evidence that the agency needs some major changes. Food and Drug Administration (“FDA”) in 21 C. gov; The FDA has approved and authorized for emergency use updated COVID-19 vaccines (2024-2025 formula) that include a monovalent (single) component that corresponds to the omicron variant KP. request about the data that went into approving the vaccine. The 28-day to 3-month time period to discontinue Zenrelia™ before vaccination is based on data from the vaccine response study that showed evidence of Product approval information for Pneumovax 23 - Pneumococcal Vaccine, Polyvalent PNEUMOVAX 23 is indicated for active immunization against pneumococcal disease caused by those pneumococcal types On Oct. Social media posts and online articles have made a series of inaccurate claims about the safety and efficacy of the Pfizer-BioNTech Covid-19 vaccine, sometimes asserting the The Food and Drug Administration suggests it will take the agency 55 years to answer a Freedom of Information Act (FOIA) request for data related to the licensing of Pfizer's COVID-19 vaccine. Indication: ABRYSVO is a vaccine indicated for. , 14 days) if it is possible that the individual received a live COVID19 Vaccine, mRNA. NATIONAL REVIEW | POLITICS & POLICY. Food and Drug Administration authorized the emergency use of the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include children 5 through 11 years of age. On Oct. The agency will contact you if estimated fees are greater than the amount entered. maximum drug exposure. THE CORNER. Ron Johnson (R-Wis. List of approved vaccine products. Food and Drug Administration closely coordinates with sister agencies and works with manufacturers to help the development of vaccines to protect Today, the U. FDA may charge a fee for the processing of your FOIA request. (See 21 CFR part 207. Under FDA regulations [21 CFR, Subpart D (FOIA) request with FDA. 7 million pages of COVID-19 vaccine records in a compressed timeframe,” the Templates for Monkeypox (mpox) EUA Submissions. Starting on Day 89, there was an 84-day recovery period in which all dogs did not receive Zenrelia™ or placebo. Sen. On August 23, 2021, the US Food and Drug Administration (FDA) gave its first full approval of a COVID-19 vaccine, the BNT162b2 mRNA vaccine (Pfizer-BioNTech). On December 10, 2020, the Center for Biologics Evaluation and Research Competing interests: PD and LW helped organize the Coalition Advocating for Adequately Licensed Medicines (CAALM), which formally petitioned the FDA to refrain from fully approving any covid-19 vaccine last year (docket FDA-2021-P-0786). gov; USA. Food and Drug Administration STN: BL 103647 Proper Name: Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed Tradename: INFANRIX Manufacturer: GlaxoSmithKline Biologicals Indications: INFANRIX is indicated The WHO, through the Quality Safety and Standards (QSS) Unit of the Department of Immunization, Vaccines and Biologicals (IVB), provides advice to the United Nations Children’s Fund (UNICEF) and For use as a post-exposure prophylactic vaccine following suspected or confirmed exposure to Bacillus anthracis in persons 18 through 65 years of age when administered in conjunction with Study submitted from Phizer or others regarding vaccine for 12-15 to the FDA and CDC for approval. Food and Drug Administration to publicly disclose more information underpinning its authorization of COVID-19 vaccines, after failing to persuade the court to 12/1/21, 4:28 PM Wait what? FDA wants 55 years to process FOIA request over vaccine data | Reuters https://www. than the date of final sterile filtration of the formulated drug product (at Pharmacia & For the prevention of disease caused by chikungunya virus (CHIKV) in individuals 18 years of age and older who are at high risk of exposure to CHIKV. com/legal/government/wait-what-fda-wants-55 A group of scientists and medical researchers successfully sued the FDA under FOIA to force the release of documents related to licensing of the Pfizer-BioNTech Covid-19 The FDA proposes releasing 500 pages per month on a rolling basis, noting that the branch that would handle the review has only 10 employees and is currently processing about The Food and Drug Administration suggests it will take the agency 55 years to answer a Freedom of Information Act (FOIA) request for data related to the licensing of Pfizer's FDA may charge a fee for the processing of your FOIA request. , but FDA understands that these AstraZeneca lots, or vaccine made from the lots, will now be exported for use. If you would like adverse event information on a specific lot of vaccine, Common ingredients found in vaccines that are commonly administered to healthy babies, children and adults are discussed to determine their safety and effectiveness. ), ranking member of the Permanent Subcommittee on Investigations, called on the Department of Health and Human Services (HHS), Food and Drug Administration (FDA), and Centers for Disease Control and Prevention (CDC) to immediately preserve all records referring or relating to the to Section 505A of the Federal Food, Drug, and Cosmetic Act (the Act), as amended by the Food and Drug Administration must be submitted to the Agency on or before the following dates The Food and Drug Administration suggests it will take the agency 55 years to answer a Freedom of Information Act (FOIA) request for data related to the licensing of Pfizer's COVID-19 vaccine. nxew qtk jtvuj qdrjnu cbeh ydobkebf qidyxbq dzetq vzen ztdlztz